We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.6B
AUM Growth
+$769M
(+16%)
Cap. Flow
+$469M
Cap. Flow
% of AUM
8.38%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
1,266
New
125
Increased
352
Reduced
429
Closed
264
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$58.9M |
| 2 |
EOG Resources
EOG
|
+$37.7M |
| 3 |
Yum! Brands
YUM
|
+$29.2M |
| 4 |
Agilent Technologies
A
|
+$25.5M |
| 5 |
Occidental Petroleum
OXY
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$27.1M |
| 2 |
Intercontinental Exchange
ICE
|
+$26M |
| 3 |
Global Payments
GPN
|
+$24.2M |
| 4 |
Cadence Design Systems
CDNS
|
+$22.8M |
| 5 |
Apple
AAPL
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.55% |
| 2 | Financials | 15.15% |
| 3 | Healthcare | 14.96% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LITS
876
Lite Strategy Inc
LITS
$33.6M
| $226K | ﹤0.01% |
6,421
-3,190
| -33% | -$107K |
|
|
IMBI
877
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $226K | ﹤0.01% |
+9,854
| New | +$187K |
|
878
ResMed
RMD
$28.3B
| $225K | ﹤0.01% |
3,470
-59,100
| -94% | -$3.93M |
|
|
HTLF
879
DELISTED
Heartland Financial USA, Inc.
HTLF
| $225K | ﹤0.01% |
6,240
| – | – |
|
|
NAME
880
DELISTED
Rightside Group, Ltd.
NAME
| $224K | ﹤0.01% |
24,636
-8,116
| -25% | -$85.1K |
|
881
Bloomin' Brands
BLMN
$680M
| $223K | ﹤0.01% |
12,960
| – | – |
|
|
HGG
882
DELISTED
hhgregg Inc.
HGG
| $223K | ﹤0.01% |
121,060
-300
| -0.2% | -$595 |
|
883
Triumph Financial Inc
TFIN
$1.84B
| $221K | ﹤0.01% |
11,126
-1,400
| -11% | -$25.4K |
|
884
Choice Hotels
CHH
$5.03B
| $220K | ﹤0.01% |
4,880
-14,730
| -75% | -$707K |
|
|
EPZM
885
DELISTED
Epizyme, Inc
EPZM
| $220K | ﹤0.01% |
22,400
-15,800
| -41% | -$144K |
|
|
886
Cadence Design Systems
CDNS
$90B
| $219K | ﹤0.01% |
8,590
-911,220
| -99% | -$22.8M |
|
|
ICAD
887
DELISTED
iCAD Inc
ICAD
| $219K | ﹤0.01% |
42,097
+1,800
| +4% | +$9.57K |
|
888
Manitowoc
MTW
$516M
| $219K | ﹤0.01% |
+11,425
| New | +$231K |
|
889
Stock Yards Bancorp
SYBT
$2.41B
| $218K | ﹤0.01% |
+6,600
| New | +$201K |
|
|
TLRA
890
DELISTED
Telaria, Inc.
TLRA
| $217K | ﹤0.01% |
126,860
-4,500
| -3% | -$7.94K |
|
891
New Jersey Resources
NJR
$6.06B
| $215K | ﹤0.01% |
6,530
-990
| -13% | -$35K |
|
|
DXYN
892
DELISTED
Dixie Group Inc
DXYN
| $215K | ﹤0.01% |
42,920
+18,500
| +76% | +$76.2K |
|
|
PCTI
893
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $214K | ﹤0.01% |
40,417
-18,200
| -31% | -$92.3K |
|
|
NNA
894
DELISTED
Navios Maritime Acquisition Corporation
NNA
| $213K | ﹤0.01% |
10,509
-280
| -3% | -$6.19K |
|
|
KIN
895
DELISTED
Kindred Biosciences, Inc.
KIN
| $213K | ﹤0.01% |
42,663
-8,000
| -16% | -$33.8K |
|
|
SAFE
896
Safehold
SAFE
$1.19B
| $208K | ﹤0.01% |
+3,986
| New | +$204K |
|
|
DALN
897
DELISTED
DallasNews
DALN
| $207K | ﹤0.01% |
7,029
-5,457
| -44% | -$129K |
|
|
TBCH
898
Turtle Beach Corp
TBCH
$239M
| $207K | ﹤0.01% |
39,423
| – | – |
|
|
HTB
899
HomeTrust Bancshares
HTB
$818M
| $205K | ﹤0.01% |
11,084
-2,929
| -21% | -$55.2K |
|
900
Upland Software
UPLD
$12M
| $204K | ﹤0.01% |
2,320
-50
| -2% | -$4.19K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2016 Portfolio in Review
As of Q3 2016, Jacobs Levy Equity Management held 1,266 positions worth $5.6B, up 16% from $4.83B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management deployed $469M of net new capital in Q3 2016, opening 125 new positions and adding to 352 existing holdings. Its largest new stake was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Intercontinental Exchange, an estimated $26M trimmed.
- Jacobs Levy Equity Management's largest Q3 2016 buy was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
- Jacobs Levy Equity Management added most to Agilent Technologies in Q3 2016, an estimated $25.5M increase.
- Jacobs Levy Equity Management's biggest Q3 2016 reduction was Intercontinental Exchange, cutting an estimated $26M.
- Jacobs Levy Equity Management fully exited Gen Digital in Q3 2016, selling an estimated $27.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $5.6B portfolio in Q3 2016.
- Jacobs Levy Equity Management opened 125 new positions and closed 264 in Q3 2016.
- Jacobs Levy Equity Management's portfolio value rose 16% quarter-over-quarter to $5.6B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.